EligibleTrials

SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

Recruiting · NCT07145190 · Observational (researchers observe without assigning treatment) · Lead sponsor: Bial - Portela C S.A.

View the official record on ClinicalTrials.gov →
Parkinson's disease

Interventions studied

SL-APO

What this trial is about

The purpose of the study is to generate real-world evidence data for the on-demand treatment with SL-APO, focusing on understanding its usage and titration practices including individual dose determination after dose-adjustment to ultimately understand their influence in patient satisfaction, treatment persistence, and the balance between effectiveness and safety. The data may help optimize titration approaches to better meet the patient's needs.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

12 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.